Nootropics
Selank
Selank is an anxiolytic peptide studied for stress and focus research. Below, we compare vendors currently stocking research-grade Selank — not just a single sales page.
Selank is an anxiolytic peptide studied for stress and focus research. Below, we compare vendors currently stocking research-grade Selank — not just a single sales page.
Prices and testing claims are pulled from each vendor's product listing. Always confirm current price and COA (Certificate of Analysis) on the vendor's site before buying.
| Vendor | Price | Purity Testing | Code | |
|---|---|---|---|---|
 Amino ClubBest Value |
From $29.95 | Third-party COA | Buy Here → | |
 UK Sarms |
£25.00 | Third-party COA | Auto-applied | Buy Here → |
 American Peptides |
$65.00 | Third-party COA | Buy Here → | |
 Amino Vault |
$75.65 | Third-party COA | Buy Here → |
Selank is a synthetic peptide analog of tuftsin, an immunomodulatory tetrapeptide, extended with additional amino acids for improved stability. It was developed in Russia and has been studied there for several decades as both an anxiolytic and nootropic research candidate.
Research-grade Selank is typically supplied as a lyophilized powder or pre-mixed solution in sealed vials, commonly at 5mg to 10mg strengths, intended for laboratory research use only.
Selank is studied for its effects on the GABAergic and serotonergic systems, and research has also examined its influence on brain-derived neurotrophic factor (BDNF) expression, mechanisms researchers have proposed underlie its studied anxiolytic and cognitive effects.
A substantial share of the Selank literature, originating largely from Russian research institutions, has examined its effects in animal models of anxiety-like behavior without the sedative profile associated with benzodiazepines.
Selank has also been studied for effects on learning and memory consolidation in animal models, an area of research interest that overlaps with its proposed influence on neurotrophic signaling.
Selank is approved as a prescription anxiolytic in Russia but does not hold FDA approval in the United States, and comprehensive Western clinical trial data is limited. Reported concerns in available research and anecdotal reports are generally mild, including nasal irritation with intranasal administration, though independent, large-scale human safety data remains limited outside Russian trials.
Clinical protocols studied in Russian trials used intranasal administration; no FDA-established human dosage exists in the United States, and research-grade material should be used per applicable laboratory protocols only.
Compound X does not sell Selank directly. We provide independent research, comparisons and vendor links — see the vendor comparison table above for current US, UK, Canada and Australia options.
Selank research is indexed on PubMed under search terms such as "Selank tuftsin analog" and "Selank anxiolytic peptide."
New guides, vendor comparisons and compound breakdowns every week.